Skip to main content
Caplight Logo









Mave Health

Mave Health

Private
BangaloreHealthcare & Life Scienceshttps://www.mavehealth.com/

Last Round

Seed

Mar 19, 2026

Total Funding Raised

$2.85M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Mave Health is a neurotechnology company that develops and produces a non-invasive wearable headset designed to improve focus, mood, and stress regulation through transcranial direct current stimulation (tDCS).

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, D2C Brands

Business Model

B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

transcranial direct current stimulationtDCSneurostimulationmental health techwearable medical deviceat-home depression treatmentnon-invasive brain stimulationbiohackingdigital therapeuticsnon-pharmacological treatmentneuromodulationD2C healthmental health appbrain tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mave Health Comparables

Compare Mave Health with similar companies based on industry and business-model similarity.

Mave Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Flow Neuroscience
86%
Marbles Health
78%
Sooma
78%

Mave Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 19, 2026
Pre SeedApr 3, 2024

Key People

Founding team and executive leadership

Dhawal Jain

Co-Founder And CEO

Founding Team

Mave Health Investors

Notable investors and investment history

Mave Health investors
InvestorRounds
All In CapitalSeed, Pre Seed
Stanford AngelsSeed
Aureolis VenturesSeed
iSeedPre Seed
Inuka CapitalSeed
Blume VenturesSeed
Bharat Founders FundPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased from 0 to 9, representing 32% of headcount.

  • Mar 19, 2026

    $2.1M raised in Seed round.

Mave Health Filings

Explore SEC and related filing metadata, where available.

Mave Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mave Health's valuation, stock price, and market status.

Is Mave Health a public or private company?

Mave Health is a private company.

What is the current stock price of Mave Health?

Mave Health is a private company with no public stock price. No recent secondary market data is available.

How much is Mave Health worth (valuation)?

Valuation information for Mave Health is not publicly available.

Can I buy Mave Health stock?

Mave Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mave Health's last funding round?

Mave Health's most recent funding round was Seed on March 18, 2026.

Who are the main investors in Mave Health?

Key investors in Mave Health include Blume Ventures.

Will Mave Health IPO soon?

No public IPO plans have been announced for Mave Health.

How can I track Mave Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mave Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range20
Year Founded2023
Last FundingMar 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?